株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の術後疼痛管理市場の分析

Global Market Study on Postoperative Pain Management: North America Expected to Remain Most Attractive Regional Market Owing to Reimbursement on Postoperative Pain Management for Prescription of High Price Opioids

発行 Persistence Market Research 商品コード 718328
出版日 ページ情報 英文 245 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.69円で換算しております。
Back to Top
世界の術後疼痛管理市場の分析 Global Market Study on Postoperative Pain Management: North America Expected to Remain Most Attractive Regional Market Owing to Reimbursement on Postoperative Pain Management for Prescription of High Price Opioids
出版日: 2018年09月05日 ページ情報: 英文 245 Pages
概要

当レポートでは、世界の術後疼痛管理市場を調査し、市場の概要、医薬品クラス・投与経路・流通経路・地域・国別の市場規模の推移と予測、市場動向、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • 市場の定義
  • 市場区分

第3章 市場機会の分析

  • マクロ経済要因
  • 市場機会分析

第4章 市場背景

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場動向
  • 規制シナリオ

第5章 世界経済の見通し

第6章 主な内容

  • 主な流通業者のリスト

第7章 北米の術後疼痛管理市場

  • イントロダクション
  • 市場分析と予測:国別
    • 米国
    • カナダ
  • 市場分析と予測:医薬品クラス別
    • オピオイド
    • 非ステロイド性抗炎症薬(NSAIDS)
    • 局所麻酔薬
    • アセトアミノフェン
  • 市場分析と予測:投与経路別
    • 注射
    • 経口投与
    • 局所投与
    • 経皮投与
    • その他
  • 市場分析と予測:流通経路別
    • 病院薬局
    • 小売薬局
    • ドラッグストア
    • 診療所
    • その他
  • 市場魅力分析:セグメント別
  • 参入企業の市場集中度
  • 成長要因と阻害要因 - 影響分析

第8章 ラテンアメリカの術後疼痛管理市場

  • イントロダクション
  • 市場分析と予測:国別
    • ブラジル
    • メキシコ
    • その他
  • 市場分析と予測:セグメント別
  • 市場魅力分析:セグメント別
  • 参入企業の市場集中度
  • 成長要因と阻害要因 - 影響分析

第9章 欧州の術後疼痛管理市場

  • イントロダクション
  • 市場分析と予測:国別
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • その他
  • 市場分析と予測:セグメント別
  • 市場魅力分析:セグメント別
  • 参入企業の市場集中度
  • 成長要因と阻害要因 - 影響分析

第10章 中国を除くアジア太平洋地域の術後疼痛管理市場

  • イントロダクション
  • 市場分析と予測:国別
    • 日本
    • インド
    • オーストラリア・ニュージーランド
    • ASEAN
    • その他
  • 市場分析と予測:セグメント別
  • 市場魅力分析:セグメント別
  • 参入企業の市場集中度
  • 成長要因と阻害要因 - 影響分析

第11章 中国の術後疼痛管理市場

  • イントロダクション
  • 市場分析と予測:セグメント別
  • 市場魅力分析:セグメント別
  • 参入企業の市場集中度
  • 成長要因と阻害要因 - 影響分析

第12章 中東・アフリカの術後疼痛管理市場

  • イントロダクション
  • 市場分析と予測:国別
    • 南アフリカ
    • 湾岸協力会議(GCC)
    • その他
  • 市場分析と予測:セグメント別
  • 市場魅力分析:セグメント別
  • 参入企業の市場集中度
  • 成長要因と阻害要因 - 影響分析

第13章 予測要因:関連性と影響力

第14章 予測の前提条件

第15章 市場構造の分析

  • 市場構造の分析:企業階層別
  • 企業シェア分析

第16章 競合情勢

  • 市場構造の分析
  • コンペティションダッシュボード
  • 競合ベンチマーキング
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • Allergan plc
    • Mylan N.V.
    • Pfizer Inc.
    • Purdue Pharma L.P
    • Janssen Pharmaceuticals, Inc.
    • Endo International plc
    • Pacira Pharmaceuticals Inc.
    • Egalet Corporation
    • GlaxoSmithKline Plc.

第17章 世界の術後疼痛管理市場:地域別

  • イントロダクション/主な所見
  • 市場分析と予測:地域別
  • 市場魅力分析:地域別

第18章 世界の術後疼痛管理市場:医薬品クラス別

  • イントロダクション/主な所見
  • 市場分析と予測:医薬品クラス別
  • 市場魅力分析:医薬品クラス別

第19章 世界の術後疼痛管理市場:投与経路別

  • イントロダクション/主な所見
  • 市場分析と予測:投与経路別
  • 市場魅力分析:投与経路別

第20章 世界の術後疼痛管理市場:流通経路別

  • イントロダクション/主な所見
  • 市場分析と予測:流通経路別
  • 市場魅力分析:流通経路別

第21章 市場分析と予測

  • 市場規模の予測
  • 前年比成長率の分析

第22章 調査方法

図表

List of Tables

  • Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
  • Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
  • Table 03 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 04 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 05 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
  • Table 06 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
  • Table 07 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 08 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 09 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
  • Table 10 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
  • Table 11 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 12 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 13 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
  • Table 14 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
  • Table 15 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 16 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 17 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
  • Table 18 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
  • Table 19 : China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 20 : China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
  • Table 21 : China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
  • Table 22 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 23 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 24 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
  • Table 25 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
  • Table 26 : Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
  • Table 27 : Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
  • Table 28 : Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
  • Table 29 : Global Prescription Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel

List of Figures

  • Figure 01 : Global Postoperative Pain Management Market value (US$ Mn) Forecast, 2018 - 2026
  • Figure 02 : Global Postoperative Pain Management Market Share, By Drug Class (2018)
  • Figure 03 : Global Postoperative Pain Management Market Share, By Region (2018)
  • Figure 04: Global Healthcare Expenditure in US$ Tn (2013-2020)
  • Figure 05 : North America Postoperative Pain Management Market Share, By Drug Class (2018 E)
  • Figure 06 : North America Postoperative Pain Management Market Share, By Route of Administration (2018 E)
  • Figure 07 : North America Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
  • Figure 08 : North America Postoperative Pain Management Market Share, By Country (2018 E)
  • Figure 09 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 10 : North America Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 11 : U.S. Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 12 : U.S. Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 13 : Canada Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 14 : Canada Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 15 : North America Postoperative Pain Management Market Attractiveness Analysis, By Country
  • Figure 16 : North America Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
  • Figure 17: North America Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration
  • Figure 18 : North America Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
  • Figure 19 : Latin America Postoperative Pain Management Market Share, By Drug Class (2018 E)
  • Figure 20 : Latin America Postoperative Pain Management Market Share, By Route of Administration (2018 E)
  • Figure 21 : Latin America Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
  • Figure 22 : Latin America Postoperative Pain Management Market Share, By Country (2018 E)
  • Figure 23 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 24 : Latin America Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 25 : Brazil Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 26 : Brazil Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 27 : Mexico Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 28 : Mexico Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 29 : Rest of Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 30 : Rest of Latin America Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 31 : Latin America Postoperative Pain Management Market Attractiveness Analysis, , By Country
  • Figure 32 : Latin America Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
  • Figure 33 : Latin America Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
  • Figure 34 : Latin America Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
  • Figure 35 : Europe Postoperative Pain Management Market Share, By Drug Class (2018 E)
  • Figure 36 : Europe Postoperative Pain Management Market Share, By Route of Administration (2018 E)
  • Figure 37 : Europe Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
  • Figure 38 : Europe Postoperative Pain Management Market Share, By Country (2018 E)
  • Figure 39 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 40 : Europe Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 41 : U.K. Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 42 : U.K. Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 43 : Germany Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 44 : Germany Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 45: France Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 46 :France Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 47 : Italy Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 48 :Italy Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 49 : Spain Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 50 : Spain Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 51 : Russia Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 52 : Russia Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 53 : Rest of Europe Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 54 : Rest of Europe Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 55 : Europe Postoperative Pain Management Market Attractiveness Analysis, , By Country
  • Figure 56 : Europe Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
  • Figure 57 : Europe Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
  • Figure 58 : Europe Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
  • Figure 59 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Drug Class (2018 E)
  • Figure 60 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Route of Administration (2018 E)
  • Figure 61 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
  • Figure 62 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Country (2018 E)
  • Figure 63 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 64 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 65 : Japan Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 66 : Japan Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 67 : India Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 68 : India Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 69 : Australia and New Zealand Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 70 : Australia and New Zealand Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 71 : ASEAN Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 72 : ASEAN Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 73 : Rest of Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 74 : Rest of Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 75 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, , By Country
  • Figure 76 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
  • Figure 77 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
  • Figure 78 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
  • Figure 79 : China Postoperative Pain Management Market Share, By Drug Class (2018 E)
  • Figure 80 : China Postoperative Pain Management Market Share, By Route of Administration (2018 E)
  • Figure 81 : China Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
  • Figure 82 : China Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 83 : China Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 84 : China Postoperative Pain Management Market Attractiveness Analysis, , By Drug Class
  • Figure 85 : China Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration
  • Figure 86 : China Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
  • Figure 87 : Middle East & Africa Postoperative Pain Management Market Share, By Drug Class (2018 E)
  • Figure 88 : Middle East & Africa Postoperative Pain Management Market Share, By Route of Administration (2018 E)
  • Figure 89 : Middle East & Africa Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
  • Figure 90 : Middle East & Africa Postoperative Pain Management Market Share, By Country (2018 E)
  • Figure 91 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 92 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 93 : South Africa Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 94 : South Africa Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 95 : GCC Countries Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 96 : GCC Countries Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 97 : Rest of Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 98 : Rest of Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 99 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, , By Country
  • Figure 100 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, By Drug Class

Figure 101 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration

  • Figure 102 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
  • Figure 103 : Global Prescription Analgesics Market Value (US$ Mn), By Region, 2018 & 2026
  • Figure 104 : Global Postoperative Pain Management Market Attractiveness Analysis, By Region (2018 - 2026)
  • Figure 105 : Global Postoperative Pain Management Market Value (US$ Mn), By Drug Class, 2018 & 2026
  • Figure 106 : Global Postoperative Pain Management Market Attractiveness Analysis, By Drug Class (2018 - 2026)
  • Figure 107 :Global Prescription Analgesics Market Value (US$ Mn), By Route of Administration, 2018 & 2026
  • Figure 108 : Global Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration (2018 - 2026)
  • Figure 109 : Global Postoperative Pain Management Market Value (US$ Mn), By Distribution Channel, 2018 & 2026
  • Figure 110 : Global Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel (2018 - 2026)
  • Figure 111 : Global Postoperative Pain Management Historical Market Size and Y-o-Y, 2013- 2017.
  • Figure 112 : Global Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2026.
  • Figure 113 : Global Postoperative Pain Management Market Absolute $ Opportunity, 2017-2026,
目次

This Persistence Market Research (PMR) report examines the 'Global Postoperative Pain Management Market' for the period 2018-2026. The primary objective of the report is to offer updates and information related to market opportunities in the global Postoperative Pain Management Market.

The Postoperative Pain Management Market is segmented as Follows:

Postoperative Pain Management Market, by Drug Class

Postoperative Pain Management Market, by Route of Administration

Postoperative Pain Management Market, by Distribution Channel

Postoperative Pain Management Market, by Region

This report covers the global Postoperative Pain Management Market performance in terms of revenue contribution from various segments. The report begins with an overview of the postoperative pain management and its definitions. The market viewpoints section underlines macro-economic factors influencing the growth of the postoperative pain management market along with detailing its opportunity analysis.

The global Postoperative Pain Management Market is segmented based on drug class, route of administration, distribution channel and region. On the basis of drug class, the market has been segmented as opioids, NSAIDS, local anaesthetics, and acetaminophen.

On the basis of route of administration, the market has been segmented as Injectable, Oral, Topical, Transdermal, Others.

On the basis of distribution channel, the market is segmented as hospital pharmacies, retail pharmacies, drug store, clinics, others.

A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index. The regional market dynamics provide the key growth driver, restraints, and trends pertaining to each region. The forecast of the Postoperative Pain Management Market by country, drug class, route of administration, distribution channel are represented in the tabular form for each region. This section also helps to understand the opportunity of the postoperative pain management market in major countries by each segment. The volume analysis of postoperative pain management is also provided by region. The volume of postoperative pain management is triangulated with the average selling price.

In the next section of the report, the 'Competitive Landscape' is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. This section also provide wise structure analysis to understand the tier structure of postoperative pain management market. Along with tier structure this section is also assessed market share analysis for top companies to cross validated the postoperative pain management market value. This analysis is done on granular level by analysing the revenue generated by each of the manufacturer from postoperative pain management. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the market segments. Detailed profiles of players in the postoperative pain management market are also provided in the report, which highlights company description, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of the report highlights the postoperative pain management market outlook for 2018-2026 and sets the forecast within the context of the postoperative pain management market by region. The key regions assessed in this postoperative pain management market report include North America, Latin America, Europe, Asia Pacific excluding China, China and Middle East and Africa. A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index. This section helps to analyses the maturity level of all the region in global postoperative pain management market.

The above sections - by drug class, route of administration and distribution channel; evaluate the historic market analysis for the period of 2013-2017 and growth prospects of the postoperative pain management market for the period 2018-2026. Along with historic analysis, market value forecast and Y-o-Y analysis by drug class, route of administration and distribution channel for postoperative pain management market is also provided in this section. We have considered 2017 as the base year and provided data for the forecast period.

The final section of report represents the global scenario for the postoperative pain management market along with Y-o-Y growth and market forecast till 2026. This section also evaluates the global market opportunity over the forecast period and also the absolute dollar opportunity for each year. This section will help to understand the overall market growth of the postoperative pain management market and the opportunity analysis for each year over the forecast period. This section also provide with the volume analysis for global postoperative pain management market to analyse the global sale of postoperative pain management drugs.

Research Methodology:

Initially top down analysis is used to calculate the market size of global postoperative pain management market. Firstly total number of surgical procedure performed annually in top 20 countries is analysed by secondary research.

The number of surgery performed and treated for postoperative pain management is also differentiated for top 20 countries.

The Number of procedure perform by surgeon and number of postoperative pain management prescriptions is confirmed by primary interviews with surgeon and nurses to analyse the volume of postoperative pain management drugs. Prices of various carpal tunnel release systems available in the market are analysed to calculate the average selling price of postoperative pain management drugs by weighted average methodology. The volume of postoperative pain management drugs is them multiplied with average selling price to obtain the market value of postoperative pain management in 2017 for top countries.

Bottom-up approach is used to validate the total market size obtained. The forecast presented in the report provides total revenue of the postoperative pain management market over 2018-2026. While forecasting the market size, we have considered the impact of several factors such product approvals for postoperative pain management drugs, R&D investment by major players, pipeline analysis, penetration of products in all Distribution channel, generic penetration across all regions, etc. However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Postoperative Pain Management Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis

4. Market Background

  • 4.1. Market Dynamics
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Trends
  • 4.2. Regulatory Scenario

5. Global Economic Outlook

  • 5.1. Gross Domestic Product by Region & Country, 2006 - 2021
  • 5.2. Global Healthcare Market Outlook

6. Key Inclusions

  • 6.1. Key Distributors List

7. North America Postoperative Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Market Size (US$ Mn) Forecast By Coun
  • 7.4. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013-2017
    • 7.4.1. Opioids
    • 7.4.2. NSAIDS
    • 7.4.3. Local Anaesthetics
    • 7.4.4. Acetaminophen
  • 7.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2026
  • 7.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 7.6.1. Injectable
    • 7.6.2. Oral
    • 7.6.3. Topical
    • 7.6.4. Transdermal
    • 7.6.5. Others
  • 7.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 7.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2017
    • 7.8.1. Hospital Pharmacies
    • 7.8.2. Retail Pharmacies
    • 7.8.3. Drug Store
    • 7.8.4. Clinics
    • 7.8.5. Others
  • 7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 7.10.Market Attractiveness Analysis
    • 7.10.1. By Country
    • 7.10.2. By Drug Class
    • 7.10.3. By Route of Administration
    • 7.10.4. By Distribution Channel
  • 7.11.Key Market Participants - Intensity Mapping
  • 7.12.Drivers and Restraints - Impact Analysis

8. Latin America Postoperative Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2012-2016
    • 8.2.1. Brazil
    • 8.2.2. Mexico
    • 8.2.3. Rest of Latin America
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 8.4. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013-2017
    • 8.4.1. Opioids
    • 8.4.2. NSAIDS
    • 8.4.3. Local Anaesthetics
    • 8.4.4. Acetaminophen
  • 8.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2026
  • 8.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 8.6.1. Injectables
    • 8.6.2. Oral
    • 8.6.3. Topical
    • 8.6.4. Transdermal
    • 8.6.5. Others
  • 8.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 8.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2017
    • 8.8.1. Hospital Pharmacies
    • 8.8.2. Retail Pharmacies
    • 8.8.3. Drug Store
    • 8.8.4. Clinics
    • 8.8.5. Others
  • 8.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 8.10.Market Attractiveness Analysis
    • 8.10.1. By Country
    • 8.10.2. By Drug Class
    • 8.10.3. By Route of Administration
    • 8.10.4. By Distribution Channel
  • 8.11.Key Market Participants - Intensity Mapping
  • 8.12.Drivers and Restraints - Impact Analysis

9. Europe Postoperative Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 9.1. Introduction
  • 9.2. Regional Market Trends
  • 9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
    • 9.3.1. U.K.
    • 9.3.2. Germany
    • 9.3.3. France
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Russia
    • 9.3.7. Rest of Europe
  • 9.4. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 9.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013-2017
    • 9.5.1. Opioids
    • 9.5.2. NSAIDS
    • 9.5.3. Local Anaesthetics
    • 9.5.4. Acetaminophen
  • 9.6. Market Size (US$ Mn) Forecast By Drug Class, 2018-2026
  • 9.7. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 9.7.1. Injectables
    • 9.7.2. Oral
    • 9.7.3. Topical
    • 9.7.4. Transdermal
    • 9.7.5. Others
  • 9.8. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 9.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2017
    • 9.9.1. Hospital Pharmacies
    • 9.9.2. Retail Pharmacies
    • 9.9.3. Drug Store
    • 9.9.4. Clinics
    • 9.9.5. Others
  • 9.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 9.11.Market Attractiveness Analysis
    • 9.11.1. By Country
    • 9.11.2. By Drug Class
    • 9.11.3. By Route of Administration
    • 9.11.4. By Distribution Channel
  • 9.12.Key Market Participants - Intensity Mapping
  • 9.13.Drivers and Restraints - Impact Analysis

10. Asia Pacific Excluding China Postoperative Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 10.1.Introduction
  • 10.2.Regional Market Trends
  • 10.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
    • 10.3.1. Japan
    • 10.3.2. India
    • 10.3.3. Australia and New Zealand
    • 10.3.4. ASEAN
    • 10.3.5. Rest of Asia Pacific
  • 10.4.Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 10.5.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013-2017
    • 10.5.1. Opioids
    • 10.5.2. NSAIDS
    • 10.5.3. Local Anaesthetics
    • 10.5.4. Acetaminophen
  • 10.6.Market Size (US$ Mn) Forecast By Drug Class, 2018-2026
  • 10.7.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 10.7.1. Injectables
    • 10.7.2. Oral
    • 10.7.3. Topical
    • 10.7.4. Transdermal
    • 10.7.5. Others
  • 10.8.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 10.9.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2017
    • 10.9.1. Hospital Pharmacies
    • 10.9.2. Retail Pharmacies
    • 10.9.3. Drug Store
    • 10.9.4. Clinics
    • 10.9.5. Others
  • 10.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 10.11.Market Attractiveness Analysis
    • 10.11.1. By Country
    • 10.11.2. By Drug Class
    • 10.11.3. By Route of Administration
    • 10.11.4. By Distribution Channel
  • 10.12. Key Market Participants - Intensity Mapping
  • 10.13. Drivers and Restraints - Impact Analysis

11. China Postoperative Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 11.1.Introduction
  • 11.2.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013-2017
    • 11.2.1. Opioids
    • 11.2.2. NSAIDS
    • 11.2.3. Local Anaesthetics
    • 11.2.4. Acetaminophen
  • 11.3.Market Size (US$ Mn) Forecast By Drug Class, 2018-2026
  • 11.4.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 11.4.1. Injectables
    • 11.4.2. Oral
    • 11.4.3. Topical
    • 11.4.4. Transdermal
    • 11.4.5. Others
  • 11.5.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 11.6.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2017
    • 11.6.1. Hospital Pharmacies
    • 11.6.2. Retail Pharmacies
    • 11.6.3. Drug Store
    • 11.6.4. Clinics
    • 11.6.5. Others
  • 11.7.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 11.8.Market Attractiveness Analysis
    • 11.8.1. By Drug Class
    • 11.8.2. By Route of Administration
    • 11.8.3. By Distribution Channel
  • 11.9.Key Market Participants - Intensity Mapping
  • 11.10. Drivers and Restraints - Impact Analysis

12. Middle East & Africa Postoperative Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 12.1.Introduction
  • 12.2.Regional Market Trends
  • 12.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
    • 12.3.1. South Africa
    • 12.3.2. GCC Countries
    • 12.3.3. Rest of MEA
  • 12.4.Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 12.5.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013-2017
    • 12.5.1. Opioids
    • 12.5.2. NSAIDS
    • 12.5.3. Local Anaesthetics
    • 12.5.4. Acetaminophen
  • 12.6.Market Size (US$ Mn) Forecast By Drug Class, 2018-2026
  • 12.7.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 12.7.1. Injectables
    • 12.7.2. Oral
    • 12.7.3. Topical
    • 12.7.4. Transdermal
    • 12.7.5. Others
  • 12.8.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 12.9.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2017
    • 12.9.1. Hospital Pharmacies
    • 12.9.2. Retail Pharmacies
    • 12.9.3. Drug Store
    • 12.9.4. Clinics
    • 12.9.5. Others
  • 12.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 12.11.Market Attractiveness Analysis
    • 12.11.1. By Country
    • 12.11.2. By Drug Class
    • 12.11.3. By Route of Administration
    • 12.11.4. By Distribution Channel
  • 12.12. Key Market Participants - Intensity Mapping
  • 12.13. Drivers and Restraints - Impact Analysis

13. Forecast Factors: Relevance and Impact

14. Forecast Assumptions

15. Market Structure Analysis

  • 15.1.Market Structure Analysis by Tier
  • 15.2.Company Share Analysis (2017)

16. Competition Landscape

  • 16.1.Market Structure Analysis
  • 16.2.Competition Dashboard
  • 16.3.Competition Benchmarking
  • 16.4.Company Deep Dive
    • 16.4.1. Teva Pharmaceutical Industries Ltd.
      • 16.4.1.1. Overview
      • 16.4.1.2. Product and Application Portfolio
      • 16.4.1.3. Production Footprint
      • 16.4.1.4. Sales Footprint
      • 16.4.1.5. Channel Footprint
      • 16.4.1.6. Strategy
        • 16.4.1.6.1. Marketing Strategy
        • 16.4.1.6.2. Product Strategy
        • 16.4.1.6.3. Channel Strategy
    • 16.4.2. Novartis AG
      • 16.4.2.1. Overview
      • 16.4.2.2. Product and Application Portfolio
      • 16.4.2.3. Production Footprint
      • 16.4.2.4. Sales Footprint
      • 16.4.2.5. Channel Footprint
      • 16.4.2.6. Strategy
        • 16.4.2.6.1. Marketing Strategy
        • 16.4.2.6.2. Product Strategy
        • 16.4.2.6.3. Channel Strategy
    • 16.4.3. Allergan plc
      • 16.4.3.1. Overview
      • 16.4.3.2. Product and Application Portfolio
      • 16.4.3.3. Production Footprint
      • 16.4.3.4. Sales Footprint
      • 16.4.3.5. Channel Footprint
      • 16.4.3.6. Strategy
        • 16.4.3.6.1. Marketing Strategy
        • 16.4.3.6.2. Product Strategy
        • 16.4.3.6.3. Channel Strategy
    • 16.4.4. Mylan N.V.
      • 16.4.4.1. Overview
      • 16.4.4.2. Product and Application Portfolio
      • 16.4.4.3. Production Footprint
      • 16.4.4.4. Sales Footprint
      • 16.4.4.5. Channel Footprint
      • 16.4.4.6. Strategy
        • 16.4.4.6.1. Marketing Strategy
        • 16.4.4.6.2. Product Strategy
        • 16.4.4.6.3. Channel Strategy
    • 16.4.5. Pfizer Inc.
      • 16.4.5.1. Overview
      • 16.4.5.2. Product and Application Portfolio
      • 16.4.5.3. Production Footprint
      • 16.4.5.4. Sales Footprint
      • 16.4.5.5. Channel Footprint
      • 16.4.5.6. Strategy
        • 16.4.5.6.1. Marketing Strategy
        • 16.4.5.6.2. Product Strategy
        • 16.4.5.6.3. Channel Strategy
    • 16.4.6. Purdue Pharma L.P
      • 16.4.6.1. Overview
      • 16.4.6.2. Product and Application Portfolio
      • 16.4.6.3. Production Footprint
      • 16.4.6.4. Sales Footprint
      • 16.4.6.5. Channel Footprint
      • 16.4.6.6. Strategy
        • 16.4.6.6.1. Marketing Strategy
        • 16.4.6.6.2. Product Strategy
        • 16.4.6.6.3. Channel Strategy
    • 16.4.7. Janssen Pharmaceuticals, Inc.
      • 16.4.7.1. Overview
      • 16.4.7.2. Product and Application Portfolio
      • 16.4.7.3. Production Footprint
      • 16.4.7.4. Sales Footprint
      • 16.4.7.5. Channel Footprint
      • 16.4.7.6. Strategy
        • 16.4.7.6.1. Marketing Strategy
        • 16.4.7.6.2. Product Strategy
        • 16.4.7.6.3. Channel Strategy
    • 16.4.8. Endo International plc
      • 16.4.8.1. Overview
      • 16.4.8.2. Product and Application Portfolio
      • 16.4.8.3. Production Footprint
      • 16.4.8.4. Sales Footprint
      • 16.4.8.5. Channel Footprint
      • 16.4.8.6. Strategy
        • 16.4.8.6.1. Marketing Strategy
        • 16.4.8.6.2. Product Strategy
        • 16.4.8.6.3. Channel Strategy
    • 16.4.9. Pacira Pharmaceuticals Inc.
      • 16.4.9.1. Overview
      • 16.4.9.2. Product and Application Portfolio
      • 16.4.9.3. Production Footprint
      • 16.4.9.4. Sales Footprint
      • 16.4.9.5. Channel Footprint
      • 16.4.9.6. Strategy
        • 16.4.9.6.1. Marketing Strategy
        • 16.4.9.6.2. Product Strategy
        • 16.4.9.6.3. Channel Strategy
    • 16.4.10. Egalet Corporation
      • 16.4.10.1. Overview
      • 16.4.10.2. Product and Application Portfolio
      • 16.4.10.3. Production Footprint
      • 16.4.10.4. Sales Footprint
      • 16.4.10.5. Channel Footprint
      • 16.4.10.6. Strategy
        • 16.4.10.6.1. Marketing Strategy
        • 16.4.10.6.2. Product Strategy
        • 16.4.10.6.3. Channel Strategy
    • 16.4.11. GlaxoSmithKline Plc.
      • 16.4.11.1. Overview
      • 16.4.11.2. Product and Application Portfolio
      • 16.4.11.3. Production Footprint
      • 16.4.11.4. Sales Footprint
      • 16.4.11.5. Channel Footprint
      • 16.4.11.6. Strategy
        • 16.4.11.6.1. Marketing Strategy
        • 16.4.11.6.2. Product Strategy
        • 16.4.11.6.3. Channel Strategy

17. Global Postoperative Pain Management Market Analysis 2013-2017 and Forecast 2018-2026, By Region

  • 17.1.Introduction/Key Findings
  • 17.2.Historical Market Size (US$ Mn) Analysis By Region, 2013-2017
  • 17.3.Market Size (US$ Mn) Forecast By Region, 2018-2026
    • 17.3.1. North America
    • 17.3.2. Latin America
    • 17.3.3. Europe
    • 17.3.4. Asia Pacific excluding China
    • 17.3.5. China
    • 17.3.6. Middle East & Africa
  • 17.4.Market Attractiveness Analysis By Region

18. Global Postoperative Pain Management Analysis 2013-2017 and Forecast 2018-2026, By Drug Class

  • 18.1.Introduction/Key Findings
  • 18.2.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013-2017
    • 18.2.1. NSAIDS
    • 18.2.2. Opioids
    • 18.2.3. Local Anaesthetics
    • 18.2.4. Acetaminophen
  • 18.3.Market Size (US$ Mn) Forecast By Drug Class, 2018-2026
  • 18.4.Market Attractiveness Analysis By Drug Class

19. Global Postoperative Pain Management Market Analysis 2013-2017 and Forecast 2018-2026, By Route of Administration

  • 19.1.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 19.1.1. Injectables
    • 19.1.2. Oral
    • 19.1.3. Topical
    • 19.1.4. Transdermal
    • 19.1.5. Others
  • 19.2.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 19.3.Market Attractiveness Analysis By Route of Administration

20. Global Postoperative Pain Management Market Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel

  • 20.1.Introduction/Key Findings
  • 20.2.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2017
    • 20.2.1. Hospital Pharmacies
    • 20.2.2. Retail Pharmacies
    • 20.2.3. Drug Store
    • 20.2.4. Clinics
    • 20.2.5. Others
  • 20.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 20.4.Market Attractiveness Analysis By Distribution Channel

21. Global Postoperative Pain Management Market Analysis 2013-2017 and Forecast 2018-2026

  • 21.1.Market Value Projections
  • 21.2.Y-o-Y Growth Analysis
  • 21.3.Absolute $ Opportunity

22. Research Methodology

Back to Top